This action helps inhibit processes that lead to beta-cell apoptosis, and clinical trials have indicated that verapamil can sustain C-peptide levels while reducing insulin requirements in newly diagnosed T1D patients [42]. This evidence concerns the gene INS and type 1 diabetes mellitus.